Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

Immune checkpoint inhibitors (ICI) have shown positive results in patients with hepatocellular carcinoma (HCC). As liver function contributes to prognosis, its precise assessment is necessary for the safe prescribing and clinical development of ICI in HCC. We tested the accuracy of the albumin-bilir...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, David J., Kaneko, Takahiro, Saeed, Anwaar, Pressiani, Tiziana, Kaseb, Ahmed, Wang, Yinghong, Szafron, David, Jun, Tomi, Dharmapuri, Sirish, Naqash, Abdul Rafeh, Muzaffar, Mahvish, Navaid, Musharraf, Lee, Chieh-Ju, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Hildebrand, Hannah, Abugabal, Yehia I., Ang, Celina, Marron, Thomas U., Khan, Uqba, Personeni, Nicola, Rimassa, Lorenza, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408648/
https://www.ncbi.nlm.nih.gov/pubmed/32664319
http://dx.doi.org/10.3390/cancers12071862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408648/
https://www.ncbi.nlm.nih.gov/pubmed/32664319
http://dx.doi.org/10.3390/cancers12071862

Ejemplares similares